Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

Acibadem University2,197 enrolled

Overview

Human metapneumovirus (HMPV) is primarily recognized as a childhood pathogen, but its impact on adults remains largely underestimated. This study investigates the prevalence, clinical characteristics, and post-COVID-19 trends of HMPV infection among adults in Istanbul, Turkey.

Study Type

OBSERVATIONAL

Enrollment

2,197

Conditions

The Prevalance of HMPV After COVID-19 Pandemic The Importance of Accurate Diagnosis for HPMV

Interventions

ObservationOTHER

Analyse of data from adults with respiratory tract infections who were tested for various respiratory viruses using a multiplex PCR assay

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults \>18 years * Patients with acute respiratory tract infection symptoms * Patients who underwent multiplex PCR testing for respiratory viruses Exclusion Criteria: * Patients for whom no respiratory viral panel test was conducted

Locations (1)

Acibadem University

Istanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

Prevalence of HMPV infection in adults pre- and post-COVID-19 pandemic

Analyse of data from adults with respiratory tract infections who were tested for various respiratory viruses using a multiplex PCR assay

Time frame: Between 2016-2020 (pre-COVID) and 2021-2023 (post-COVID)

Secondary Outcomes

Comparison of HMPV with other respiratory viruses in adults

Analyse of data from adults with respiratory tract infections who were tested for various respiratory viruses using a multiplex PCR assay

Time frame: Between 2016-2020 (pre-COVID) and 2021-2023 (post-COVID)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.